Targeting <scp>DDX</scp> 3 with a small molecule inhibitor for lung cancer therapy
2015 · EMBO Molecular Medicine · 212 citations
https://doi.org/10.15252/emmm.201404368
F
Farhad Vesuna
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
99
Papers
3.6K
Citations
26
h-index
36
i10-index
Farhad Vesuna is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: RNA Research and Splicing & RNA modifications and cancer & Cancer Cells and Metastasis. The author has an h-index of 26, co-authored 85 publications.
ORCID: 0000-0002-0356-5096Papers by this author
worksPeptides Derived from Type IV Collagen, CXC Chemokines, and Thrombospondin-1 Domain-Containing Proteins Inhibit Neovascularization and Suppress Tumor Growth in MDA-MB-231 Breast Cancer Xenografts
2009 · Neoplasia · 66 citations
https://doi.org/10.1593/neo.09620
Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33
2018 · Translational Oncology · 46 citations
https://doi.org/10.1016/j.tranon.2018.09.002
HOXA5 Regulates hMLH1 Expression in Breast Cancer Cells
2006 · Neoplasia · 31 citations
https://doi.org/10.1593/neo.05766
DExD-box RNA helicases in human viral infections: Pro- and anti-viral functions
2025 · Antiviral Research · 3 citations
https://doi.org/10.1016/j.antiviral.2025.106098
Additional file 3: of Genomic pathways modulated by Twist in breast cancer
2017 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.c.3665737_d10
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat